Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
With a market cap of 33.11B, Natera(NTRA) trades at $235.40. The stock has a price-to-earnings ratio of -103.06.
During the trading session on 2025-12-23, Natera(NTRA) shares reached a daily high of $236.99 and a low of $232.08. At a current price of $235.40, the stock is +1.4% higher than the low and still -0.7% under the high.
Trading activity shows a volume of 993.18K, compared to an average daily volume of 1.37M.
The stock's 52-week range extends from a low of $125.38 to a high of $246.90.
The stock's 52-week range extends from a low of $125.38 to a high of $246.90.
NTRA News
Canaccord raised the firm’s price target on Natera (NTRA) to $285 from $260 and keeps a Buy rating on the shares. The firm previewed its life science tools and...
Natera recently reported that the phase III CALGB (Alliance)/SWOG 80702 trial, now published in JAMA Oncology, showed that adding celecoxib to FOLFOX chemothera...
